Use of breast-conserving surgery for treatment of stage I and stage II breast cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
E GuadagnoliS B Soumerai

Abstract

To assess the use of breast-conserving surgery in two states reported to differ with respect to surgical treatment of breast cancer. A retrospective cohort study based on data collected from medical records and patients was performed among 1,514 patients diagnosed with early-stage breast cancer in Massachusetts and 1,061 patients in Minnesota. Patients were identified at 18 randomly selected hospitals in Massachusetts and at 30 hospitals in Minnesota. The rate of breast-conserving surgery in both states and the correlates of breast-conserving surgery among women eligible for the procedure were determined. The rate of breast-conserving surgery in both states was much higher than previously reported. Among those eligible for the procedure, nearly 75% underwent breast-conserving surgery in Massachusetts and nearly half did so in Minnesota. Significantly (P < .003) more women who underwent mastectomy in Minnesota (27%) than in Massachusetts (15%) reported that their surgeon did not discuss breast-conserving surgery with them. Among women who underwent mastectomy and who reported being informed of both surgical alternatives, more women (P < .001) in Minnesota (74%) than in Massachusetts (62%) said they ultimately chose mastectomy be...Continue Reading

Citations

Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MorrowD Winchester
Jan 5, 2002·Annals of Surgical Oncology·D I GregorioK Zarfos
Apr 5, 2003·Annals of Surgery·Raimund JakeszUNKNOWN Austrian Breast & Colorectal Cancer Study Group
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingEdward Guadagnoli
Oct 6, 2006·Expert Review of Anticancer Therapy·Michael S Sabel
Nov 9, 2012·Annals of Surgical Oncology·Shayna L ShowalterBrian J Czerniecki
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B E HillnerC E Desch
Mar 18, 2004·Journal of the National Cancer Institute·Nancy N BaxterTodd M Tuttle
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingJane C Weeks
Jul 1, 2005·Journal of General Internal Medicine·Jeanne S MandelblattUNKNOWN Breast Cancer in Older Women Research Consortium
Jul 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Walley J TempleMichael Eliasziw
Dec 7, 2010·Journal of Women's Health·Celia P KaplanLeah Karliner
Feb 27, 2003·The Breast Journal·Shahla Masood
Jun 24, 2004·Journal of the American Geriatrics Society·Rose C MalyRebecca A Silliman
Apr 2, 2004·American Journal of Clinical Oncology·Antonio P LegorretaRobert G Parker
Mar 7, 2002·BMC Cancer·Gertraud MaskarinecBrian F Issell
Dec 23, 2006·Breast Cancer Research and Treatment·Nicole Hébert-CroteauJacques Brisson
Apr 9, 2010·Breast Cancer Research and Treatment·Nancy L KeatingRita Volya
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L WarrenGerald F Riley
Aug 6, 2003·Disease Management : DM·Timothy D Costich, Frederick C Lee
Aug 13, 2009·Expert Review of Anticancer Therapy·Phuong Tran, Ian S Fentiman
Sep 6, 2012·Breast Cancer Research and Treatment·Rachel A FreedmanNancy L Keating
Feb 7, 2002·European Journal of Cancer Care·Z H WuJ S Goodman
Sep 7, 2002·Cancer·Valerie L StaradubMonica Morrow
Dec 2, 2008·Journal of Psychosocial Oncology·Sabrina T WongT Gregory Hislop
Sep 15, 2005·Cancer·Steven J KatzMonica Morrow
Feb 24, 2010·BMC Health Services Research·Myung Kyung LeeYoung Ho Yun
Feb 13, 2016·Breast Cancer Research and Treatment·Ines Vaz-LuisNancy U Lin
Nov 9, 2005·Journal of the American Geriatrics Society·Timothy L LashRebecca A Silliman
Jun 3, 1999·The New England Journal of Medicine·H J BursteinJ C Weeks
May 19, 2007·Annals of Surgical Oncology·Diane OpattSteven J Katz
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel PolskyKevin A Schulman
Dec 21, 2004·The British Journal of Surgery·D B KingsmoreW D George

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.